1. Home
  2. RCAT vs DBVT Comparison

RCAT vs DBVT Comparison

Compare RCAT & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$15.56

Market Cap

957.4M

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$20.51

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCAT
DBVT
Founded
2002
2002
Country
United States
France
Employees
N/A
90
Industry
Wholesale Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
957.4M
1.1B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
RCAT
DBVT
Price
$15.56
$20.51
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$16.33
$31.75
AVG Volume (30 Days)
15.6M
213.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,836,382.00
$4,151,000.00
Revenue This Year
$438.56
$65.50
Revenue Next Year
$265.21
$47.02
P/E Ratio
N/A
N/A
Revenue Growth
79.95
N/A
52 Week Low
$4.60
$3.91
52 Week High
$18.78
$26.19

Technical Indicators

Market Signals
Indicator
RCAT
DBVT
Relative Strength Index (RSI) 59.50 45.16
Support Level $10.39 $20.23
Resistance Level $17.83 $25.00
Average True Range (ATR) 1.73 1.59
MACD 0.26 -0.24
Stochastic Oscillator 59.71 34.74

Price Performance

Historical Comparison
RCAT
DBVT

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: